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Abstract
Closure of the ductus arteriosus (DA) at birth is essential for the transition from fetal to postnatal life. Before birth the DA
bypasses the uninflated lungs by shunting blood from the pulmonary trunk into the systemic circulation. The molecular
mechanism underlying DA closure and degeneration has not been fully elucidated, but is associated with apoptosis and
cytolytic necrosis in the inner media and intima. We detected features of histology during DA degeneration that are
comparable to Hutchinson Gilford Progeria syndrome and ageing. Immunohistochemistry on human fetal and neonatal DA,
and aorta showed that lamin A/C was expressed in all layers of the vessel wall. As a novel finding we report that progerin, a
splicing variant of lamin A/C was expressed almost selectively in the normal closing neonatal DA, from which we
hypothesized that progerin is involved in DA closure. Progerin was detected in 16.2%67.2 cells of the DA. Progerin-
expressing cells were predominantly located in intima and inner media where cytolytic necrosis accompanied by apoptosis
will develop. Concomitantly we found loss of a-smooth muscle actin as well as reduced lamin A/C expression compared to
the fetal and non-closing DA. In cells of the adjacent aorta, that remains patent, progerin expression was only sporadically
detected in 2.5%61.5 of the cells. Data were substantiated by the detection of mRNA of progerin in the neonatal DA but
not in the aorta, by PCR and sequencing analysis. The fetal DA and the non-closing persistent DA did not present with
progerin expressing cells. Our analysis revealed that the spatiotemporal expression of lamin A/C and progerin in the
neonatal DA was mutually exclusive. We suggest that activation of LMNA alternative splicing is involved in vascular
remodeling in the circulatory system during normal neonatal DA closure.
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Introduction
The fetal ductus arteriosus (DA) is a muscular artery connecting
the aortic arch and pulmonary trunk (Fig. 1a). The DA shunts
deoxygenated blood from the fetal right ventricle into the
umbilico-placental circulation, where gaseous exchange takes place.
Prenatally, the DA is indispensable. After birth, as blood becomes
oxygenated in the lungs, the DA rapidly contracts followed by
anatomical definitive closure (Fig. 1a, b,f). The histological features
of the normal closing muscular DA as well as the elastic structure of
the aorta are depicted schematically (Fig. 1d,e). DA closure is
incomplete in about 10% of neonates [1] causing a patent or
persistent DA (PDA). This is the third most common congenital
heart defect [2]. Normal closure of the DA, which can take place in
both healthy neonates as well as in neonates with congenital heart
malformations, is mediated by two processes, vascular smooth
muscle cell (VSMC) contraction, and anatomical closure on the
basis of tissue degeneration [1,3–5]. Contraction of VSMCs in the
DA results from the rapid rise in oxygen tension after delivery [6].
Anatomical closure in humans starts already in the second trimester
fetus by the initiation of intimal thickening which is regulated by the
prostaglandin (PGE) receptor, EP4 [7] via the protein kinase A and
Epac regulatory pathways [8]. After birth following contraction
there are major changes in the inner media characterized by
extracellular matrix deposition followed by apoptosis and cytolytic
necrosis (CN) (Fig. 1d). Eventually a DA ligament (Fig. 1f) is formed
[3–5,9]. The molecular regulation of DA regression in the neonate
is still incompletely understood.
The anatomical process of postnatal DA closure and regression is
common in mammals but the timing of the processes regulating DA
closure varies between species. In humans DA maturation already
starts in the prenatal period but without strict correlation between
gestational age, postnatal age and the degree of maturation [1]. For
medical purposes, it is crucial to study the spatiotemporal regulation
of DA regression in the prenatal and postnatal period [3–5]. In
neonates with ductus-dependent heart anomalies, systemic admin-
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e23975istration of PGE can prevent constriction of the DA [10]. Unre-
stricted flow via an open DA is essential forthose neonatesuntil they
can undergo corrective surgery. Histological characteristics of the
DA ofhealthyneonatesandthosewith heartanomalies areidentical
[3] and similarly influenced by PGE [11]. This offers a unique
opportunity to study DA remodeling using surgical biopsy
specimens.
Children with Hutchinson Gilford Progeria Syndrome (HGPS)
develop progressive arterial occlusive disease and will eventually
die due to severe atherosclerosis, see [12]. HGPS is caused by a
mutation in LMNA, which leads to accumulation of a truncated
lamin A protein, progerin, at the nuclear lamina [13]. Arteries of
HGPS patients exhibit intimal thickening with dense fibrosis and
thinning of the adjacent media [14]. Relative to lesions in typical
atherosclerosis, the atheromatous core tends to be smaller [14] or
even absent [15] in HGPS arteries. Reduced numbers of VSMCs
in the aortic media was a prominent finding in a murine HGPS
model [12]. Marked adventitial fibrosis in arteries and veins has
been added to the spectrum of vascular lesions in HGPS [14].
The anatomical remodeling process that converts the muscular
DA vessel of the fetus and neonate into the fibrous structure of the
ligamentum arteriosum is characterized by intimal thickening
without an atheromatous core. Furthermore, loss of VSMC in
the inner media and intima are due to CN [4,5,9]. Although
degeneration during closure of the DA and vascular pathology in
HGPS is not identical, the similarities in intimal thickening and
loss of VCMCs warrant the hypothesis that progerin may also
play a role in the DA closure. Here, we show that progerin is
Figure 1. Schematic presentations of the great vessels. Anatomy of DA and the adjacent arteries. (a) A patent DA is found in the fetus before
respiration starts. Oxygen-rich blood (in red) from the placenta passes though the aorta. Oxygen-poor blood from the fetus (in blue) passes the DA
entering the descending aorta (in purple). (b) After the start of respiration the DA regresses into a ligamentum arteriosum. Aortic (red) and pulmonary
(blue) circulation are disconnected. (c) In aortic coarctation, a left sided heart malformation, the DA is kept open by administration of PGE allowing
blood to enter the systemic circulation. Dashed lines indicate the plane of tissue sections shown in d–h. Transverse sections of the muscular DA (d;1
in c), the elastic aorta (e;2 in a), and the ligamentum arteriosum (f;3 in b). Intimal thickening in the DA is indicated in yellow. Areas with CN are
indicated in white and the wavy elastic lamellae with blue. Endothelial cells (red outlines) line the inside of the vessels. Longitudinal sections through
the DA (4 in a, providing Fig. 1g, and 5 in c providing Fig. 1h). (g) DA tissue and aorta tissue are merging and can be separately distinguished by their
characteristic histology. (h) In coarctation, inner media and intimal thickening of the DA extend into the aorta sometimes almost encircling the lumen
of the aortic arch at that site (as depicted). The aortic tissue will always be present in the roof of the coarctation.
doi:10.1371/journal.pone.0023975.g001
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with developing CN, while Lamin A/C is hardly expressed in
these regions. The molecular and cellular implications of these
novel findings are discussed.
Results
To determine whether progerin is expressed in neonatal DA,
reverse transcriptase (RT) PCR was performed on fresh and frozen
biopsiesofDAthat were collectedduringcorrective cardiac surgery.
The expression of progerin mRNA was analyzed in neonatal DA
sections using primers that cover the progerin cryptic site [16]. The
full length mRNA PCR product is 270 bp (Fig. 2A). In addition a
185 bp product representing the delta 10 isoform was amplified in
theDAand aortatissues.Importantly,intheneonatalDAbutnotin
aorta tissue a 120 bp PCR product was found (Fig. 2A). These PCR
products were evaluated by sequencing analysis which confirmed
that the 120 bp fragment corresponds to progerin whereas the
270 bp fragment is of LMNA full length mRNA (Fig. 2B). It is
relevant to note that in the analyzed biopsies this primer set led to
unspecific PCR products (i.e. a 100 bp fragment; Fig. 2A).
Therefore, it was essential to confirm LMNA gene products by
sequencing of the PCR products. The housekeeping beta
glucuronidase (GUSB) gene was used as a control [17] and PCR
product was found in all tissues. In total, progerin PCR product was
found in all 6 DA samples analyzed, but was not detected in the two
aorta samples. Aorta and DA are physically connected, while
remodeling in neonates is limited to the DA, suggesting an
association between progerin and DA remodeling.
The low level of progerin mRNA in DA indicates that the
protein would be expressed at very low levels or in only part of the
cells. Progerin and lamin A/C protein expression was analyzed
with immunohistochemistry using antibodies that specifically
recognize progerin or lamin A/C [16]. Due to irreversible
farnesylation at the C-terminus, progerin accumulates at the
nuclear lamina [18]. In contrast, lamin A/C is also found in the
nucleoplasm [18]. Indeed, confocal microscopy revealed progerin
expression (Figure 3A,c), at the nuclear lamina, while lamin A/C
exhibited an additional nucleoplasm distribution (Fig. 3A,b). This
confirms that the two antibodies recognize different proteins.
Progerin expression in neonatal DA was found in a large
number of cells, while in the aorta its expression was less
prominent (Fig. 3B b,e). We determined that the mean fraction of
progerin expressing cells in the DA was 16.2%67.2 while in the
aorta it was only 2.5%61.5 (Fig. 3C,a) indicative for a tissue-
specific expression of progerin. Since the major histological
difference between the DA and aorta in neonates is degeneration
of the inner media and the intima, we determined progerin
expression across the DA layers. A higher fraction of progerin
positive cells was found in the intima and inner media (25%6
15.0), compared to the outer media (11%611.2) (Fig. 3C,b). This
difference in the spatial distribution of progerin was statistically
significant. TUNEL staining of the neonatal DA, indicative of
apoptosis, was predominantly found in the inner media bordering
the intima (Fig. 4a–d). As cytolytic necrosis will initially develop in
cells of the intima and inner media, the high expression of progerin
in these layers supports a functional relationship with cell death.
The spatial overlap in the DA between progerin expression and
TUNEL, suggests a causal relation between progerin expression
and apoptosis in the development of CN.
Progerin expression was analyzed in 16 neonatal DA biopsies
(including 2 with adjacent aortic tissue) with various degrees of CN
development. Furthermore, specimen from a 14- and an 18-week-
old fetus and a PDA from a 2-year-old child were studied. In the
fetal DA CN is not developed, and, as expected, uniform SM-actin
staining was found across the DA layers (Fig. 5A). Regression of the
normal neonatal closing DA is characterized by a reduced
expression of contractile proteins, such as alpha-SM-actin in the
inner media [5,9]. In the DA from neonate I (Fig. 5B) SM-actin
expression in the inner media was less intense compared to the
adjacent wall layers. In the same area from the 10-day-old infant II
(Fig. 5C), however, prominent CN in the inner media was present
showing a zone without cells and complete absence of alpha-SM-
actin expression (Fig. 5C). These represent two subsequent stages in
the degeneration of the neonatal DA. Spatially unchanged SM-
actin staining was exhibited in the PDA (Fig. 5D) similar to the fetal
DA. In both the fetal and PDA without CN, progerin expression
was not detected (Figure 5A,D). In contrast, in the DA of both
neonates progerin expression was found in the intima and inner
mediabutnotintheoutermedia(Fig.5B,C),whereVSMCsremain
present throughout ligament formation.
Since progerin is a splicing variant of the lamin A gene, we
investigated the expression pattern of lamin A/C in the DA.
Lamin A/C expression was found in all nuclei in the fetal DA
(Fig. 5A), but in neonatal DA the expression was markedly less in
areas of developing CN (Fig. 5B,C). Lamin A/C was found in all
layers in the PDA (Fig. 5D) indicating a spatiotemporal association
between lamin A/C expression and the development of CN in the
normal closing neonatal DA.
Discussion
The molecular mechanisms that are involved in DA closure are
poorly understood. Here we report, for the first time, progerin
Figure 2. RT-PCR reveals expression of progerin mRNA in DA. A. RT-PCR analysis of LMNA and progerin mRNA in neonatal aorta and DA was
performed with primers that amplify 270 and 185 bp of LMNA, and 120 bp of progerin. GUSB PCR product was used as a control. Aorta tissue was
obtained from a 4-month patient and DA tissues from 6 neonates 8 days after birth. B. Direct sequencing of PCR fragments 270, 185 and 120 bp.
Shown are the sequence histograms from position 2212 bp.
doi:10.1371/journal.pone.0023975.g002
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progerin predominantly in the neonatal but not in the fetal DA, and
in a higher number of cells in intima and inner media, compared to
theoutermediaandtotheaorta.Thisspatialandtemporalprogerin
expression pattern highly correlates with CN development in the
degenerating neonatal DA implying a functional rolefor progerin in
CN development. Abnormal DA closure was not reported so far in
HGPS patients or in the HGPS mouse models. To confirm a role
for progerin in DA closure detailed studies in neonatal HGPS
models and patients are relevant.
Figure 3. Spatial changes of progerin expression in a neonatal DA. A. (b) Confocal images of immunofluorescence show even nuclear
distribution of lamin A/C (red) and (c) nuclear envelope localization of progerin (green) in the media of DA. (a) Nuclei are counterstained with DAPI.
(d) Merging of the staining patterns. Scale bars: 5 mm. B. Microscopic image of immunofluorescence in DA and aorta (Ao) show (a,d) the tissue
specific expression of lamin A/C and (b,e) progerin. (c,f) in the media. Nuclei expressing both proteins as shown in the merged images. Scale bars:
20 mm. C. (a) Box-plot shows the percentage of progerin positive cells in DA and aorta. Statistical analysis represents 1302 nuclei in DA and 302 nuclei
in aortas from 5 individuals. P-value indicates significant difference in progerin expression between DA and aorta. (b) Histograms show the average
ratio of progerin positive cells in intima and inner media versus the outer media. Statistical analysis represents 4 samples from each of the 5
individuals. P-value indicates that intima and inner media contain significantly more progerin expressing cells than the outer media.
doi:10.1371/journal.pone.0023975.g003
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[9,19]. We show a spatial correlation between progerin expression
and frequency of apoptosis. We postulate that progerin plays a role
in cell death of smooth muscle cells in the DA. Reduction of alpha-
SM-actin was found in arteries of HGPS patients in cells
expressing progerin [13] indicating that spatial and temporal
expression of progerin correlates with development of apoptosis.
Apoptosis frequency is increased in fibroblasts from HGPS [20]
and elevated apoptosis in the mouse model for progeria is reported
[12]. The role of progerin in initiating apoptosis of cells in the
inner media and intima of the DA should be further investigated.
Elevated progerin expression was spatially associated with
reduced lamin A/C expression in the DA. These spatial changes
between lamin A/C and progerin expression in the inner media
and intima suggest an association with alternative splicing of
LMNA gene products during DA remodeling. Activation of LMNA
alternative splicing was found during cell differentiation and cell
cycle progression [21]. During postnatal cardiac development
splicing variants of ASF/SF2 and SERCA2 are activated [22,23] to
change cellular function. Lamin A/C was recently shown to play a
role in cardiac disease. In heterozygous LMNA+/2 knockout mice,
a 50% reduction in lamin A/C protein levels cause myocardial
apoptosis and cardiac abnormalities [24]. Deregulation of lamin A/
C processing correlates with atherosclerotic lesions from aged
individuals Pre-lamin A accumulates in medial VSMC from aged
individuals and in atherosclerotic lesions correlating with the down-
regulation of lamin A/C processing enzymes [25]. Based on these
studies we hypothesize that changes in lamin A/C expression and
activation of splicing variants are an alternative mechanism to
regulate cardiovascular development. Alternative splicing is affected
by oxidative stress [26]. Whether oxygen levels alter LMNA splicing
during DA closure is yet to be determined Anatomical definitive
sealing of the DA is preceded by contraction of VSMCs in which
many molecular pathways are involved [1] e.g. activated by reactive
oxygen species. Accumulation of reactive oxygen species has been
described in both the onset of DA closure [27] as well as in vascular
ageing [28]. Progerin expression in coronary arteries of non-HGPS
individuals, which significantly increases throughout life has been
associated with vascular ageing [14]. Farnesyltransferase inhibitors
(FTIs) can in part correct cellular defects caused by progerin
[29,30]. FTIs reverse the permanent farnesylation of progerin or
pre-lamin A and, thus repair structural and functional nuclear
defects. Given our finding that progerin is expressed in the neonatal
DA, itwill be relevant to study whether FTIs caninterfere with local
vascular remodeling and prevent anatomical DA closure.
Our study indicates a novel role for progerin in a programmed
cellular process although a relation between DA closure and the
process of ageing needs further clarification.
Materials and Methods
Ethics statement
The medical ethics committee of the Leiden University Medical
Center exempted this study from review because tissues normally
discarded were analyzed anonymously and waived the need for
consent due to the fact that linkage of the samples received with
individual patients was not possible.
Tissue samples
Postnatal human DA tissues were obtained during surgical
correction of cardiac anomalies. The resection of the DA was part
of the surgical strategy for aortic arch reconstruction in all cases
(see Figs. 1c,h, and dashed line 5 for site and orientation of the
dissected biopsies). Fetal tissues were acquired from post-mortem
specimens after legal or spontaneous abortion after PGE
induction. All tissues were collected and stored at the department
of Anatomy and Embryology of Leiden University. Tissue type,
diagnosis and age were recorded for this study.
Tissue samples were directly fixed in 4% phosphate-buffered
formaldehyde or 2% acetic acid in absolute ethanol at room tem-
perature.Fixed samples wereembedded inparaffinand sectionedat
5 mm.For RNAextraction orcryostat sections, samples wereplaced
in Tissue-tek, and were directly frozen in liquid nitrogen and stored
at minimal 220 C. Fetal material was obtained from 2 cases (14
and 18 weeks gestation) providing aorta and DA wall tissue.
Neonatal tissue was studied in 16 DA biopsies and two descending
aortas. The neonates (aged 3–21 days, median 10 days) were born
after 3862 weeks of gestation. All of them received a low dose of
PGE (0,0125 mg/kg/min) because of left-sided cardiac defects with
aortic arch anomalies (Fig. 1 c,h, dashed line 5). The biopsy of a
PDA came from a 2-years-old child. A part of the descending aorta
was collected from a 4-month-old infant during coarctation repair
and served as a negative control (not shown).
Immunohistochemistry microscopy and image
quantification
For a morphological overview sections were briefly (5 seconds)
counter stained with haematoxylin eosin. Antibodies used in this
study are: monoclonal lamin A/C (Chemicon International
(Temecula, CA, USA); 1:50) 1:50, a monoclonal anti-lamin A
G608 (progerin) antibody, kindly provided by K. Djabali (Dpt. of
Dermatology, Columbia University, NY, USA) and mouse
monoclonal antibody against smooth muscle alpha-actin 1A4
(1:3000; DAKO A/S Glostrup, Denmark). Antibody incubation
was performed in PBS containing 0.05% Tween 20 (PBS-T) and
1% bovine serum albumin overnight in a humidified chamber
Figure 4. Spatial distribution of TUNEL staining in the DA. (a) A
sister section of the neonatal DA from figure 3A that was stained with
TUNEL (green). Details of the staining are shown in magnifications of
the boxed areas b–d. TUNEL staining is predominantly found in the
inner media (c) and the bordering intima (b). TUNEL positive nuclei
were not found in the outer media (d). Nuclei were counter stained with
DAPI. Scale bars are: scale bar 100 mm (a); 10 mm (b,c,d).
doi:10.1371/journal.pone.0023975.g004
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was detected with either HRP-conjugated secondary antibody
(Vector Laboratories, Inc. Burlingame, CA, USA) or with a
fluorescent- conjugated secondary antibody (Goat-anti-mouse/Alex
488, Invitrogen, Corp. Carlsbad, CA, USA, Donkey-anti-mouse/
Cy3, Jackson ImmunoResearch Labaratories, West Grove, PA,
USA). The fluorescent conjugated secondary were mounted in
Citifluor (Agar Scientific) containing 400 mg/ml DAPI (Sigma-
Aldrich) and examined with a confocal laser scanning microscopy
(Leica SP5) or a Fluorescence microscope (Leica DM RXA), 636
and 1006 lens NA 1.4 plan Apo objective. Apoptotic cells were
determined using the in situ Cell Death Detection Fluorescein kit
from Roche Diagnostics (Almere, Nederland) following the
manufacturer’s instructions. Significance of statistical analysis was
performed with the unpaired T-test with Welch’s correction.
RNA isolation and RT-PCR reaction
Total RNA was extracted from frozen biopsies using the RNA-
Bee RNA extraction kit as per the manufacturer (AMS
Biotechnology, Abingdon, U.K.). 1 mg of RNA from each sample
was submitted to cDNA synthesis using the RevertAid
TM First
Strand cDNA Synthesis Kit (Fermantas, Ontario, Canada) or with
the SuperScriptH VILO
TM cDNA Synthesis Kit (Invitrogen). 1
3.4 ng of cDNA was used for PCR using primers located in exon 9
and 12 of LMNA (forward: 59 ACCCCGCTGAGTACAACCT,
and reverse: 59 TGCAGTTCTGGGGGCTCT. The primers
cover progerin cryptic site at position 2215 in LMNA mRNA, and
are2 bplongerthanthesethatwerepreviouslydescribed.Oursetof
primers gives less non-LMNA PCR products in DA and aorta as
compared those reported in [31]. PCR conditions were 35 cycles,
each cycle consisting of 30-sec denaturation at 94uC, 30-sec
annealing at 60uC, and 30-sec polymerization at 72uC. 15 mlo f
the reaction was analyzed on 2% agarose gel and stained with
ethidium bromide. PCR products were eluted from gel and were
sequenced at www.lgtc.nl. Primers for GUSB amplification are:
forward- 59CTCATTTGGAATTTTGCCGATT 39; reverse- CC-
GAGTGAAGATCCCCTTTTTA.
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Figure 5. Spatial and temporal expression of progerin is associated with development of CN in the DA. A. Overview of the wall of the
DA of an 18-week-old fetus depicting a-smooth muscle actin (aSM actin) staining of the vascular smooth muscle cells. Details of intima (i) and outer
media (om) show the absence of progerin and the overall expression of lamin A/C in the cells. B. Overview of the DA of a 10-day-old neonate with
onset of degeneration of the inner media (im). In this layer there is loss of a-SM actin staining. Details of intima and inner media show progerin
expressing nuclei (arrowheads) and reduction of lamin A/C expressing cells compared to the fetal DA in A. C. Overview of the DA of a 10-day-old
neonate with marked cytolytic necrosis (CN) in the inner media with loss of cells. Smooth muscle cells are still detectable in the intima and outer
media. Detail of the intima shows some progerin expressing nuclei (arrowheads) and absence of these nuclei in the outer media. Lamin A/C
expression is found in the inner and outer media. D. Overview of a non-closing persistent DA (PDA) of a 2-year-old infant. In all layers there is
abundant a-SM actin expression. Details of the intima and outer media show absence of progerin and presence of lamin A/C expressing cells. Scale
bars: overviews A–D 200 mm, details 50 mm.
doi:10.1371/journal.pone.0023975.g005
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